SMS Pharmaceuticals Ltd
SMSPHARMASMS Pharmaceuticals Ltd
SMSPHARMA


Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
32.32 | 2.18 | 0.25% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
44.51 | 5.11 | 0.71% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
SMS Pharmaceuticals Limited is engaged in manufacturing and sale of bulk drugs and active pharmaceutical ingredients (APIs), and their intermediates.
Investor Presentation
View olderPeers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 602.85 | 615.01 | 439.58 | 465.07 | 468.31 | 417.06 | 566.62 | 525.07 | 526.94 | 605.00 | ||||||||||
Raw Materials | 388.63 | 399.45 | 325.03 | 294.32 | 307.19 | 259.50 | 313.27 | 387.95 | 299.73 | 504.46 | ||||||||||
Power & Fuel Cost | 29.89 | 33.81 | 18.23 | 22.57 | 21.75 | 18.99 | 23.31 | 32.58 | 36.73 | |||||||||||
Employee Cost | 31.67 | 38.11 | 26.92 | 32.80 | 35.59 | 39.35 | 41.17 | 51.02 | 55.04 | |||||||||||
Selling & Administrative Expenses | 26.80 | 25.23 | 10.23 | 9.67 | 9.84 | 10.18 | 19.02 | 21.12 | 16.62 | |||||||||||
Operating & Other expenses | 23.28 | 25.59 | -17.42 | 9.97 | 0.40 | 3.90 | 45.27 | -87.41 | 59.36 | |||||||||||
EBITDA | 102.58 | 92.82 | 76.59 | 95.74 | 93.54 | 85.14 | 124.58 | 119.81 | 59.46 | 100.54 | ||||||||||
Depreciation/Amortization | 17.17 | 19.43 | 19.18 | 19.90 | 19.27 | 22.07 | 22.28 | 32.15 | 32.13 | 31.68 | ||||||||||
PBIT | 85.41 | 73.39 | 57.41 | 75.84 | 74.27 | 63.07 | 102.30 | 87.66 | 27.33 | 68.86 | ||||||||||
Interest & Other Items | 17.93 | 17.11 | 15.82 | 15.48 | 11.92 | 12.32 | 11.19 | 19.16 | 21.98 | 23.72 | ||||||||||
PBT | 67.48 | 56.28 | 41.59 | 60.36 | 62.35 | 50.75 | 91.11 | 68.50 | 5.35 | 45.14 | ||||||||||
Taxes & Other Items | 32.24 | 15.38 | 13.09 | 28.59 | 22.31 | 19.18 | 28.60 | 6.28 | 12.41 | 14.09 | ||||||||||
Net Income | 35.24 | 40.90 | 28.50 | 31.77 | 40.04 | 31.57 | 62.51 | 62.22 | -7.06 | 31.05 | ||||||||||
EPS | 4.16 | 4.83 | 3.37 | 3.75 | 4.73 | 3.73 | 7.38 | 7.35 | -0.83 | 3.67 | ||||||||||
DPS | 0.20 | 0.20 | 0.20 | 0.25 | 0.25 | 0.25 | 0.30 | 0.30 | 0.30 | 0.30 | ||||||||||
Payout ratio | 0.05 | 0.04 | 0.06 | 0.07 | 0.05 | 0.07 | 0.04 | 0.04 | — | 0.08 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFInvestor Presentation
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
SMS Pharmaceuticals Ltd | -142.15 | 2.18 | 0.25% |
Sun Pharmaceutical Industries Ltd | 34.86 | 4.98 | 0.93% |
Cipla Ltd | 34.74 | 4.10 | 0.70% |
Dr Reddy's Laboratories Ltd | 21.24 | 4.11 | 0.70% |
Price Comparison
Compare SMSPHARMA with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividend Cuts
SMSPHARMA has increased or maintained dividend levels over the last 5 years
Dividend Yield
Current dividend yield is 0.25%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹2.53 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 22, 2023
Dividend/Share
₹0.30
Ex DateEx Date
Sep 22, 2023
Cash Dividend
Ex DateEx DateSep 22, 2022
Dividend/Share
₹0.30
Ex DateEx Date
Sep 22, 2022
Cash Dividend
Ex DateEx DateSep 22, 2021
Dividend/Share
₹0.30
Ex DateEx Date
Sep 22, 2021
Cash Dividend
Ex DateEx DateMar 26, 2020
Dividend/Share
₹0.25
Ex DateEx Date
Mar 26, 2020
Cash Dividend
Ex DateEx DateSep 19, 2019
Dividend/Share
₹0.25
Ex DateEx Date
Sep 19, 2019
News & Opinions
Chemcon Speciality Chemicals Ltd leads losers in ‘B’ group
1 year ago•Business Standard
Selan Explorations Technology Ltd leads gainers in ‘B’ group
1 year ago•Business Standard
SMS Pharmaceuticals share price zooms after bagging licence to manufacture, supply oral COVID vaccines
1 year ago•Moneycontrol
SMS Pharma soars after receiving license to manufacture COVID-19 medicine
1 year ago•Business Standard
19 Indian companies get licence to make Pfizer’s oral generic
1 year ago•Economic Times
Taking Stock | Geopolitical tension roils market, indices see biggest single-day fall in nearly two years
1 year ago•Moneycontrol
SMS Pharmaceuticals consolidated net profit rises 109.94% in the September 2021 quarter
2 years ago•Business Standard
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 2.53%, vs industry avg of 8.45%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.23% to 0.17%